Direct glycosylation of the sodium salt of 4,6-dichloro-or 4,6-dibromo-2-methylthiopyrrolo[2,3-d]pyrimidine (6_ and 2) with 2,3,5-trl-0-benzoyl-J>-ribofuranosyl bromide gave good yield of the corresponding Ny-glycosylated pyrrolo[2,3-^]pyrimidine. The intermediate 4-amino-6-chloro-2-methylthio-7-p-Dribofuranosylpyrrolo[2,3-jl]pyrimidine (10) provided a new synthetic route to tubercidin, via 6-chlorotubercidin (_12). 6-Chloro-2-methoxytubercidin was also obtained from _1£ via the methylsulf one (_14). Application of this glycosylation procedure to 4,6-dichloro-or 4,6-dibromo-2-methylpyrrolo[2,3-<l]-pyrimidine (17 and _18) also furnished the corresponding N^-glycosyl derivatives with (3-configuration, 2l_ and 22. Dehalogenation of ^1 gave 2-methyltubercidin and bromination with bromine in a buffered solution gave 5,6-dihalo-2-methyltubercidin (^3). Several new 2,6-disubstituted tubercidin derivatives were prepared from these glycosyl intermediates. This new sodium salt glycosylation procedure was found to be superior to other procedures for the total synthesis of these halogenated 7-deazapurine nucleosides.
INTRODUCTION
Pyrrolo [2,3- djpyrimidine (7-deazapurine) nucleosides continue to be of considerable interest both from chemical and biological points of view. Because of the structural resemblance to purine nucleosides and the unusual biological properties of naturally occurring nucleoside antibiotics tubercidin (1), toyocamycin (2) , sangivamycin (3) and cadeguomycin (4) , there has been an ongoing effort by many investigators to develop synthetic procedures for the NHj "AT/ 00 " preparation of the nucleoside derivatives of the pyrrolo[2,3-dJpyrimidine ring system. The adenosine analog tubercidin (_1) exhibits a profound cytotoxlc effect on a variety of mammalian cell strains _lri vitro and shows significant antitumor 2-8 activity ^n vivo.
Tubercidin also affects multiplication of both DNA and 9 10
RNA viruses and inhibits the growth of a variety of microorganisms. Sangivamycin (3) has demonstrated potent activity against L1210 luekemia in mice, cytotoxicity against HeLa cells, and in a phase I toxicity study on humans produced no evidence of toxicity at maximally tolerated doses. Although the antitumor activity of toyocamycin {2) is significant, ' ' its clinical use has been precluded due to severe toxicity, suggesting that structural modifications might possibly reduce the toxicity within the acceptable limits.
Considerable effort has been expended in the development of methods for the chemical synthesis of pyrrolo [2,3- Robins and co-workers developed two separate routes for the synthesis of pyrrolo [2,3-jl] pyrimidine nucleosides. The first one involved direct fusion (acid catalyzed as well as noncatalyzed) of an appropriate 7-deazapurine and 1,2,3,-17 18 5-tetra-O-acetyl-p-D-ribofuranose. ' However, the yield of the nucleoside product was rather low. The second route utilized a trimethylsilylated 7-deazapurine and acylated sugar halide, ' by which the yield was much improved. Recently, a phase-transfer glycosylation procedure using a preformed 7-deazapurine and 2,3,5-tri-^-benzyl-D-ribofuranosyl bromide has been develop-21-23 ed by Seela and co-workers.
However, this procedure cannot generally be used for a halogenated aglycon. The yields are usually low and the removal of the blocking groups troublesome.
We have now developed a new procedure in which a halogenated pyrrolo-[2,3-dJpyrimidine can be successfully used for glycosylation studies. In this paper we describe a method for the rapid synthesis of 4,6-dihalogenated pyrrolo [2,3-d_] pyrimidine nucleosides with a 3-configuration using the sodium salt The site of bromination in _13 was determined on the basis of H NMR, which revealed the absence of a peak at 6 6.68 for the C,H proton.
Further structural proof came from elemental analysis.
The glycosylation studies were further extended to 4,6-dibromo-2-methyl- 
as the sole product in 91% yield, after silica gel column chromatography. Like the nucleoside J5, compound _19_ was also found to be unstable. Therefore, without extensive purification, _1£ was treated with methanolic ammonia at 100°C, which gave 4-amino-6-chloro-2-methyl-
A similar methodology was used to obtain the corresponding 6-bromo derivative (22) The essentially identical ultraviolet absorption spectra of 2-methyltubercidin and tubercidin (see experimental) indicated the site of glycosylation in 25, to be N_. The anomerlc configuration was assumed to be P in view of the small coupling constant of the anomeric proton in 2-methyltubercidin. This assumption was substantiated by the appearance of the C, ,H proton of 25^ at °1 25 5.90 ppm in the H NMR spectrum, which is very similar to that reported for 5-methyltubercidin (6 5.96).
EXPERIMENTAL SECTION
Melting points were taken on a Thomas-Hoover capillary melting point apparatus and are uncorrected. Nuclear magnetic resonance ( H NMR) spectra were determined at 90 MHz with JEOL FX-90Q spectrometer. The chemical shift values are expressed in 6 values (parts per million) relative to tetramethylsilane as an internal standard. (saturated at 0°C, 65 ml) was heated in a steel bomb at 120-125°C for 24 hours and the resulting brown solution was evaporated to dryness. The residue was dissolved in methanol (50 ml) and adsorbed onto silica gel (-50 g). Coevaporation with methanol (3 X 50 ml) gave a dry residue, which was placed on top of a silica gel column (3 X 45 cm) prepacked in chloroform. A solution of 19_ (5.70 g) in methanolic ammonia (saturated at 0 C, 60 ml) was heated at 100°C for 10 hours in a steel bomb (125 ml). Methanolic ammonia was evaporated and the residue was purified on a silica gel column (3 X 50 cm) prepacked in chloroform. Elution with chloroform:methanol gradient gave a homogeneous product which, after crystallization from 50% aqueous ethanol, gave To a solution of j!2_ (0.25 g, 0.0007 mol) in glacial acetic acid (7 ml) containing sodium acetate (0.245 g, 0.003 mol) was added a solution of bromine (0.14 g, 0.009 mol) in acetic acid (1 ml), dropwise. After stirring at room temperature for 15 minutes, the reaction mixture was worked up as described for J!3 to obtain 0.20 g (61%) of the title compound as the monohydrate; mp 208-210°C; 
